Grégoire Courtine
Fondateur chez ONWARD MEDICAL N.V.
Fortune : 5 M $ au 31/05/2024
Postes actifs de Grégoire Courtine
Sociétés | Poste | Début | Fin |
---|---|---|---|
ONWARD MEDICAL N.V. | Directeur/Membre du Conseil | 01/01/2014 | - |
Directeur Technique/Scientifique/R&D | 01/01/2014 | - | |
Fondateur | 01/01/2014 | - | |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Directeur/Membre du Conseil | 01/12/2014 | - |
Directeur Technique/Scientifique/R&D | 01/12/2014 | - | |
Fondateur | 01/12/2014 | - | |
Sales & Marketing | 01/12/2014 | - | |
Swiss Federal Institute of Technology | Corporate Officer/Principal | - | - |
Centre Hospitalier Universitaire Vaudois
Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Centre Hospitalier Universitaire Vaudois is a university hospital located in Lausanne, CH. The SwitzerlandUV is also a renowned center of medical education and research, collaborating with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). It has 16 clinical and medico-technical departments and is known for its academic achievements in healthcare, research, and teaching. The vast campus in the lake region is home to these institutions. The CEO of the Swiss company is Nicolas Demartines. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Grégoire Courtine
Anciens postes connus de Grégoire Courtine
Sociétés | Poste | Début | Fin |
---|---|---|---|
NeuroRestore
NeuroRestore Pharmaceuticals: MajorHealth Technology NeuroRestore is a platform of symptom-relieving drug candidates for disease states in which cognitive ability is impaired, such as Alzheimer's disease, sleep apnea, traumatic brain injury, and Parkinson's disease. NeuroRestore is based in Lausanne, Switzerland. The Swiss company stimulates specific signaling pathways in the central nervous system known as neurotrophins, which play a crucial role in the function of nerve cells. The most well-known neurotrophins are NGF (nerve growth factor) and BDNF (brain-derived neurotrophic factor). NeuroRestore's drug candidates enhance communication between nerve cells and improve cognitive ability. The private company's leading drug candidate, ACD856, has recently completed clinical phase I studies and demonstrated positive effects. | Directeur/Membre du Conseil | - | - |
Formation de Grégoire Courtine
University of Pavia | Doctorate Degree |
Statistiques
Internationale
Suisse | 5 |
Pays-Bas | 2 |
Italie | 2 |
Opérationnelle
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ONWARD MEDICAL N.V. | Commercial Services |
Entreprise privées | 3 |
---|---|
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Health Technology |
Centre Hospitalier Universitaire Vaudois
Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Centre Hospitalier Universitaire Vaudois is a university hospital located in Lausanne, CH. The SwitzerlandUV is also a renowned center of medical education and research, collaborating with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). It has 16 clinical and medico-technical departments and is known for its academic achievements in healthcare, research, and teaching. The vast campus in the lake region is home to these institutions. The CEO of the Swiss company is Nicolas Demartines. | Health Services |
NeuroRestore
NeuroRestore Pharmaceuticals: MajorHealth Technology NeuroRestore is a platform of symptom-relieving drug candidates for disease states in which cognitive ability is impaired, such as Alzheimer's disease, sleep apnea, traumatic brain injury, and Parkinson's disease. NeuroRestore is based in Lausanne, Switzerland. The Swiss company stimulates specific signaling pathways in the central nervous system known as neurotrophins, which play a crucial role in the function of nerve cells. The most well-known neurotrophins are NGF (nerve growth factor) and BDNF (brain-derived neurotrophic factor). NeuroRestore's drug candidates enhance communication between nerve cells and improve cognitive ability. The private company's leading drug candidate, ACD856, has recently completed clinical phase I studies and demonstrated positive effects. | Health Technology |
- Bourse
- Insiders
- Grégoire Courtine
- Expérience